Conferences & Events

Found 119,048 articles

• Omnicell to Present at the Piper Sandler 35th Annual Healthcare Conference

  11/27/2023

  Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023 at 1:00 p.m. ET.

• Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  Asensus Surgical, Inc. announced that the management team will participate and present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024 at 3:00pm EST.

• Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  Karyopharm Therapeutics Inc. announced that the Company's senior management team will participate at the 42nd Annual J.P. Morgan Healthcare Conference in a podium presentation on Wednesday, January 10 at 2:15 p.m. PT, followed by a question-and-answer breakout session at 2:35 p.m. PT.

• Editas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  Editas Medicine, Inc., a clinical-stage genome editing company, announced that the Company’s President and CEO Gilmore O’Neill, M.B., M.M.Sc., will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, 4:30 p.m. PT / 7:30 p.m. ET in San Francisco, CA.

• Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  Leap Therapeutics, Inc. announced that Douglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

• Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  Amicus Therapeutics announced that Bradley Campbell, President and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 8, 2024, at 2:15 p.m. PT.

• Atea Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  Atea Pharmaceuticals, Inc. announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea, will present a business update at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 10:30 a.m. PT in San Francisco, CA.

• BioCryst to Present at 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  BioCryst Pharmaceuticals, Inc. announced that the company will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 9, 2024, at 6:00 p.m. ET.

• Frontier Medicines to Present at the 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  Frontier Medicines Corporation announced that Chris Varma, Ph.D., Frontier’s co-founder, chairman, and CEO, will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 11:30 a.m. PT.

• PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference - Jan 03, 2024

  1/3/2024

  PureTech Health plc announced that Daphne Zohar, Founder and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 9:00 a.m. PST / 12:00 p.m. EST.

• Verge Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

  1/3/2024

  Verge Genomics announced that Verge Genomics’ co-founder and CEO, Alice Zhang, will present at the 42nd Annual J.P. Morgan Healthcare Conference.

• Merck to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  Merck, known as MSD outside of the United States and Canada, announced that Robert M. Davis, chairman and chief executive officer, and Dr. Dean Y. Li, executive vice president and president, Merck Research Laboratories, are scheduled to participate in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, Jan. 8, 2024, at 4:30 p.m. PST / 7:30 p.m. EST.

• South Rampart Pharma to Present at Biotech Showcase 2024

  1/3/2024

  South Rampart Pharma, Inc. announced that Hernan Bazan, MD, FACS, CEO and Co-Founder of South Rampart Pharma, will present the latest clinical and scientific data on its lead clinical asset at Biotech Showcase 2024 on Tuesday, January 9.

• Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  Immunocore Holdings plc announced that management will participate in a presentation at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California.

• Tonix Pharmaceuticals to Present at Two Upcoming Investor Conferences in January: Focus is on TNX-102 SL for the Management of Fibromyalgia Following Positive Topline Results in Second Pivotal Phase 3 Trial

  1/3/2024

  Tonix Pharmaceuticals Holding Corp. announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, will present and host investor meetings at the following January investor conferences.

• Monte Rosa Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  Monte Rosa Therapeutics, Inc. announced that Markus Warmuth, M.D., Chief Executive Officer, is scheduled to present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 3:00 p.m. PT.

• Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit

  1/3/2024

  Zura Bio Limited announced that members of its senior management team will present at two upcoming conferences in January.

• iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  iTeos Therapeutics, Inc. announced that Michel Detheux, Ph.D., President and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference being held in San Francisco, CA on Wednesday, January 10, 2024 at 3:00 p.m. PST.

• IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  IGM Biosciences, Inc. announced that Fred Schwarzer, Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 11:15 a.m. PST in San Francisco.

• Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  Voyager Therapeutics, Inc. announced that Chief Executive Officer Alfred W. Sandrock, Jr., M.D., Ph.D., will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on January 10, 2024, at 9:45 a.m. PT.